Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Applying to Texas Oncology - Austin Central · Austin, Texas
Answer a few short questions to share with the research team.